Cargando…

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report

BACKGROUND: Using traditional pharmacotherapy to treat Borderline Personality Disorder (BPD) such as mood stabilizers and second-generation antipsychotics has a lack of supporting evidence. Buprenorphine/Naloxone (BUP/N), a combination medication consisting of a partial opioid agonist, and a full op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Brenna, Inch, Katelyn M., Kaschor, Brenna A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920565/ https://www.ncbi.nlm.nih.gov/pubmed/35287724 http://dx.doi.org/10.1186/s40479-022-00181-1

Ejemplares similares

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
por: Coish, Rebecca, et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
por: Menard, Shannon, et al.
Publicado: (2021)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report
por: Sandhu, Raman, et al.
Publicado: (2019)

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
por: Rozylo, Jennifer, et al.
Publicado: (2020)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Use of Clozapine for Borderline Personality Disorder: A Case Report
por: Amamou, Badii, et al.
Publicado: (2016)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation
por: Randall, Adam, et al.
Publicado: (2023)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Borderline Personality Disorder “Discouraged Type”: A Case Report
por: Duică, Lavinia, et al.
Publicado: (2022)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report
por: MacAusland-Berg, Joshua, et al.
Publicado: (2022)

Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder
por: Wipper, Benjamin, et al.
Publicado: (2023)

Treating Borderline personality disorder with Asenapine : Case report
por: Aboelenien, S. K. I. M., et al.
Publicado: (2023)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
por: Regenstreif, Lori, et al.
Publicado: (2022)

A case report on the treatment of complex chronic pain and opioid dependence by a multidisciplinary transitional pain service using the ACT Matrix and buprenorphine/naloxone
por: Weinrib, Aliza Z, et al.
Publicado: (2017)

Experiences and Preferences of Opioid-Use-Disorder Patients Who Switched from Brand to Generic Buprenorphine/Naloxone Films: A Case Series
por: Cedeño, Erica, et al.
Publicado: (2022)

A Case of Dhat Syndrome with Borderline Personality Disorder
por: Chowdhury, A.N., et al.
Publicado: (2004)

Relapse rates among veterans on maintenance doses of combination buprenorphine and naloxone for opioid use disorder
por: Binger, Katie J., et al.
Publicado: (2020)

Sociodemographic and clinical characteristics of patients with long-term remission with buprenorphine / naloxone in opiate use disorder
por: Kahya, Y., et al.
Publicado: (2021)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
por: Osilla, Karen Chan, et al.
Publicado: (2020)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report
por: Awasthi, Harshal
Publicado: (2023)

Treatment of severe borderline personality disorder with clozapine
por: Vohra, Adarsh Kumar
Publicado: (2010)

Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders
por: Bestepe, Engin Emrem, et al.
Publicado: (2020)

Schizotypal Disorder With Borderline Personality Traits: A Case Report
por: Reddy, Rakesh Byra, et al.
Publicado: (2023)

Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
por: Hagan, Scott, et al.
Publicado: (2021)

Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder
por: Kapuganti, Amber, et al.
Publicado: (2018)

Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future
por: Clarke, Hance, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dagtvonp564tm02q9ip7gqbbd9